Review Breast Cancer Screening Public Comment (CMS #125) and Discuss Controlling High Blood Pressure Measure Updates (CMS #165) Change Review Process Meeting.

Slides:



Advertisements
Similar presentations
Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center.
Advertisements

1 Hypertension 2002: An Overview. 2 Leading Risks For Death (World Health Organization 1995)
Copyright © 2014 American Medical Group Foundation. All rights reserved. August 12, 2014 Initial Feedback Report: Hypertension Prevalence and Control.
JNC 8 Guidelines….
Dr Esther Tsang August 2011 Management of Diabetes Mellitus.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Health Maintenance And Disease Management
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
The concept of Diabetes & CV risk: A lifetime risk challenge
Blood Pressure Monitoring
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Azara Proprietary & Confidential Cervical Cancer Screening 2014 Measure Changes Improving Patient Outcomes through Data.
Epidemiology Prevalence Increase with age 25% of the white males vs. 17% in white females 44% of black males vs. 37% in black femals Indifference between.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Screening Introduction to Primary Care:
Use of Information Technology for Precision Performance Measurement and Focused Quality Improvement David W. Baker, MD MPH Chief, General Internal Medicine.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Blood pressure control in primary health care WORKSHOP
The Cost Savings and Enhancements of a District’s Wellness Program A Case Study from Broward Presented by: Kay Blake, Training Supervisor Tina Severance-Fonte,
DION GALLANT, MD PRIMARY CARE SERVICE LINE MEDICAL DIRECTOR PRESBYTERIAN MEDICAL GROUP JNC 8.
Use of Computerized Clinical Decision Support System and Registry Functions to Track and Improve Clinical Outcomes Pamela Ferrari RN Director of Performance.
Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
Morbidity and Mortality in Contemporary CAD Patients With Hypertension Treated With Either a Verapamil/Trandolapril or Beta-Blocker/Diuretic Strategy (INVEST):
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 16th Annual Report Figure Summary of BP achievements.
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) PI: Jan Hirsch, RPh, PhD Carol M. Mangione, MD, MSPH Barbara A. Levey.
Cervical Cancer Screening Measure Updates (CMS #124)
BARBER-1 (Barber-Assisted Reduction in Blood Pressure in Ethnic Residents) A randomized study investigating the effect of having the local barber encourage.
Antidepressant Medication Management Updates (CMS128) Change Review Process Meeting November 19, 2015 Jenna Williams-Bader Anne Marie Smith Stephanie Rodriguez.
Medication Dispensed vs. Ordered Change Review Process Meeting November 19, 2015 Jenna Williams-Bader Anne Marie Smith Stephanie Rodriguez.
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Updates (CMS164) Change Review Process Meeting November 19, 2015 Jenna Williams-Bader.
HIT Standards Committee Quality Workgroup Janet Corrigan National Quality Forum June 23, 2009.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
December 02 1 Vascular mortality: Age-specific hazard ratios for 20 mmHg lower usual SBP deaths at ages
Incidence of Abnormal Ankle-Brachial Index in Diabetic Patients Asymptomatic of Arteriosclerotic Vascular disease Brintha Vasagar, MD, MPH, Katee Castleman,
Monthly Metrics Forum February 2014 Appropriate Testing for Children With Pharyngitis And Appropriate Treatment for Children With Upper Respiratory Infection.
Getting Blood Pressure To Goal: a Pressurized Process Grant M. Greenberg M.D., M.A., M.S.H.A.
Free Powerpoint Templates Page 1 Using Data to Guide Improvement Presented by: Brooke Thomas, Program Advisor February 28, 2013.
Community Teaching Project: Hypertension Presented by: Mariel Alvarez, Michelle Vickers, Andy Nguyen, Lalita Poon, Minh Luong.
CHANGES in ada 2015.
Hypertension In The Stroke Patient
Basics of New PHASE Reporting
Evidence Based Screening
What’s New in the 2013 ESC/ESH Hypertension Guideline
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
1422 Pre- Diabetes and Undiagnosed HTN Measures
Hypertension Guidelines
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
End point Net change with soy supplements vs control (95% CI) p
Issues With Synthea Generated Patient Data for Use in Clinical Quality Measure – Hypertension Case Study Peter Li, OSEHRA 1/24/2019.
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Use Synthea Generated Patient Data for Clinical Quality Measure – Case Study: CMS165 Controlling High Blood Pressure Peter Li, OSEHRA 2/21/2019.
Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.
Chronic Disease Under Control: Managed Care Plan Distribution, 2006
UK Renal Registry 10th Annual Report 2007
End point Valsartan Valsartan+HCTZ p
Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.
Mean BP by visit - all patients
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Presentation transcript:

Review Breast Cancer Screening Public Comment (CMS #125) and Discuss Controlling High Blood Pressure Measure Updates (CMS #165) Change Review Process Meeting August 20, 2015 Jenna Williams-Bader Anne Marie Smith Stephanie Rodriguez

2 BCS Public Comment Summary 2 comments –Agree with grace period and alignment with USPSTF guideline –Clarification question about why eCQM and PQRS specs differ (diagnostic vs. screening mammogram) We did not receive feedback on adding exclusion criteria –Exclude women who have had a bilateral mastectomy or two unilateral mastectomies: Right and left unilateral mastectomy History of bilateral mastectomy Unilateral mastectomy with bilateral modifier Absence of left/right breast

3 BCS Recommendations for Vote Revise the age range from to years of age Extend numerator timeframe from 24 months to 27 months to allow a 3-month grace period Do not add the ““14 days apart” timing to the current exclusion “Exclude women who have had two unilateral mastectomies” Add the following exclusion criteria: –Exclude women who have had a bilateral mastectomy or two unilateral mastectomies: Right and left unilateral mastectomy History of bilateral mastectomy

4 CBP Measure Update Revise measure to align with updated guidelines Evidence-Based Guideline for the Management of High Blood Pressure in Adults –In the general population aged >= 60 years, initiate pharmacologic treatment to lower blood pressure (BP) at systolic blood pressure (SBP) >=150 mm Hg or diastolic blood pressure (DBP) >=90 mm Hg and treat to a goal SBP <150 mm Hg and goal DBP <90 mm Hg –In the general population =140 mm and Hg DBP >=90mm Hg and treat to a goal SBP <140 mm Hg and DBP <90mm Hg –In the population aged >=18 years with diabetes, initiate pharmacologic treatment to lower BP at SBP >=140mm Hg or DBP >=90mm Hg and treat to a goal SBP <140 mm Hg and goal DBP <90 mm Hg

5 Current Numerator Measure intent is to ensure adequate control of blood pressure for patients years of age who are diagnosed with hypertension Current Numerator Statement Patients whose blood pressure at the most recent visit is adequately controlled (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) during the measurement period.

6 Current Numerator Current Logic o AND: Most recent: "Occurrence A of Encounter, Performed: Adult Outpatient Visit" satisfies all o overlaps "Occurrence A of Diagnosis, Active: Essential Hypertension" o during "Measurement Period" o overlaps "Physical Exam, Performed: Diastolic Blood Pressure (result)" o overlaps "Physical Exam, Performed: Systolic Blood Pressure (result)" o AND: "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 90 mmHg) o AND: "Physical Exam, Performed: Systolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 140 mmHg)

7 Updated Numerator Patients 18–85 years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year based on the following criteria: –Patients 18–59 years of age whose BP was <140/90 mm Hg –Patients 60–85 years of age without a diagnosis of diabetes whose BP was <150/90 mm Hg –Patients 60–85 years of age with a diagnosis of diabetes whose BP was <140/90 mm Hg

8 Numerator Update Updated Logic – Part 1 o AND: Age >= 17 year(s) at: "Measurement Period" o AND: Age < 59 year(s) at: "Measurement Period" o AND: Most recent: "Occurrence A of Encounter, Performed: Adult Outpatient Visit" satisfies all o overlaps "Physical Exam, Performed: Diastolic Blood Pressure (result)" o overlaps "Physical Exam, Performed: Systolic Blood Pressure (result)" o AND: "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 90 mmHg) o AND: "Physical Exam, Performed: Systolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 140 mmHg)

9 Numerator Update Updated Logic – Part 2 o AND: Age >= 59 year(s) at: "Measurement Period" o AND: Age < 85 year(s) at: "Measurement Period" o AND NOT: "Diagnosis, Active: Diabetes" overlaps "Measurement Period" o AND: Most recent: "Occurrence A of Encounter, Performed: Adult Outpatient Visit" satisfies all o overlaps "Physical Exam, Performed: Diastolic Blood Pressure (result)" o overlaps "Physical Exam, Performed: Systolic Blood Pressure (result)" o AND: "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 90 mmHg) o AND: "Physical Exam, Performed: Systolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 140 mmHg)

10 Numerator Update Updated Logic – Part 3 o AND: Age >= 59 year(s) at: "Measurement Period" o AND: Age < 85 year(s) at: "Measurement Period" o AND: "Diagnosis, Active: Diabetes" overlaps "Measurement Period" o AND: Most recent: "Occurrence A of Encounter, Performed: Adult Outpatient Visit" satisfies all o overlaps "Physical Exam, Performed: Diastolic Blood Pressure (result)" o overlaps "Physical Exam, Performed: Systolic Blood Pressure (result)" o AND: "Physical Exam, Performed: Diastolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 90 mmHg) o AND: "Physical Exam, Performed: Systolic Blood Pressure" satisfies all Most recent: during "Occurrence A of Encounter, Performed: Adult Outpatient Visit" (result < 150 mmHg)

11 Numerator Questions Does the updated numerator logic (in red) make sense? Does it capture the intent of the measure?

12 Next Steps: Public Comment Revised changes will be posted to JIRA for a two-week public comment period Comments will be reviewed and presented at the next CRP meeting before a final recommendation is made Measures updates will be implemented during 2016 Annual Update